Nasdaq Biotechnology Index Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Nasdaq Biotechnology Index stocks.

Nasdaq Biotechnology Index Stocks Recent News

Date Stock Title
May 15 TAK Takeda dengue vaccine gets WHO clearance
May 14 TAK Update: Scilex Holding Says Federal Court Approved Settlement With Takeda Pharmaceutical in Gloperba Patent Dispute
May 14 TAK Scilex Holding Says Federal Court Approved Settlement With Takeda Pharmaceutical in Gloperba Patent Dispute
May 14 TAK Scilex wins court approval for Takeda settlement
May 14 TAK Takeda to Present Oncology Portfolio and Pipeline Data at the 2024 ASCO Annual Meeting
May 13 TAK Why Is Small-Cap Alzheimer's-Focused AC Immune Stock Trading Higher On Monday?
May 13 TAK Takeda shells out $100m to license AC Immune’s Phase II Alzheimer’s therapy
May 13 TAK AC Immune rockets 47% on Alzheimer's therapy deal with Takeda
May 13 IBB For Biotech Stocks To Move Higher, This Must Move Lower
May 13 TAK Takeda nabs option to license Alzheimer’s immunotherapies from AC Immune
May 13 TAK Takeda Pharmaceutical, AC Immune Agree to Option and Licence Agreement, Including on Alzheimer's Treatment Candidate
May 13 TAK AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease
May 10 TAK Catalyst's New CEO Has Big Ideas For The Small Biotech
May 10 TAK Takeda Pharmaceutical Company Limited (TAK) Fiscal Year 2023 Earnings Call Transcript
May 9 TAK Japan's Takeda Pharma Outlines $900M Overhaul To Boost Growth, As 2023 Profit Fall Over 50%
May 9 IBB Top 10 ETFs with cheapest skew - Barclays
May 9 TAK Takeda tackles $900m restructuring plan after generics hurt annual profits
May 9 TAK Takeda Pharmaceutical Company Limited 2023 Q4 - Results - Earnings Call Presentation
May 9 TAK Takeda seeks efficiency as operating profit slumps
May 9 TAK Takeda targets ‘efficiency’ in restructuring, pipeline cuts
Nasdaq Biotechnology Index

The NASDAQ Biotechnology Index is a stock market index made up of securities of NASDAQ-listed companies classified according to the Industry Classification Benchmark as either Biotechnology or Pharmaceuticals.

Browse All Tags